GCR Awards
Global Competition Review recognized Kirkland for representing Teva Pharmaceuticals on its acquisition of Allergan’s generics business at the 7th annual GCR Awards. The deal won the “Merger control matter of the year – Americas” award, which honors firms for “creative, strategic and innovative competition work for a client on a landmark merger control matter in the Americas.” The transaction was the largest generic drug merger of all time, tying up the first- and third-largest generic pharmaceutical producers in the world.